Bonaventura Clotet

Dr. Bonaventura Clotet was Head of the HIV Unit of the Hospital Germans Trias between 1987 and 2015 when he became Head of the Infectious Diseases Department. He is also Director of the Retrovirology Laboratory “IrsiCaixa” Foundation, since 1995, and President of the “Lluita contra la SIDA” Foundation since 1992. Since 2006, he is co-director of the HIVACAT project for the development of the AIDS vaccine in Catalonia, Spain.

He is an associate professor of Medicine at the Universitat Autònoma de Barcelona (UAB), and a Professor of the “Chair of AIDS and related diseases” at the University of VIC (UVic-UCC).

Dr. Clotet’s team is composed of 112 people working at the clinics and at the lab focusing on HIV, hepatitis, immune system and cancer, papillomavirus, metagenomics, other infectious diseases, and aging.

Dr. Clotet has created 2 spin-offs from IrsiCaixa: AELIX Therapeutics for the development of a therapeutic vaccine for HIV-infected patients and AlbaJuna Therapeutics for the development of an Immunoglobulin for curing & preventing HIV.